Human Dose Predictions from in Vitro Data to be Discussed at ADMET 2016
Summary
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site Press Releases SMi Group Press Release Receive press releases from SMi Group: By Email RSS Feeds: Human Dose Predictions from in Vitro Data to be Discussed at ADMET 2016 SMi are delighted to announce that Ken Page, Principal Scientist, RedX, has joined the speaker line-up for SMis 11th annual conference and exhibition on "ADMET" which returns to London, UK on 13th-14th June 2016 London, United Kingdom, March 10, 2016 --( Other key speakers on the agenda include: Roche, UCB Pharma, Genentech, Merck Serono, GSK, Lundbeck, Sanofi-Aventis, Takeda and many more… To download the full agenda, please visit www.admet-event.com/prcom Hosted over two days, ADMET 2016 aims to help attendees to: • Discover application of PBPK to drug development in rare diseases • Review the role of drug transporters in drug delivery to CNS diseases • Learn about better models for understanding, predicting and avoiding drug induced liver injury • Discuss in silico approaches to evidence-based mechanistic modelling • Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small molecules For those interested in attending, there is currently an early bird offer available saving £300 off of the conference price which expires on the 31st of March.We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network." His session will deliver insight into: Human dose as an excellent multi-parameter metric for directing compound optimisation; validation of human dose prediction using in vitro data and highlights of areas which can most profitably be optimised for a given series.Other key speakers on the agenda include: Roche, UCB Pharma, Genentech, Merck Serono, GSK, Lundbeck, Sanofi-Aventis, Takeda and many more…To download the full agenda, please visit www.admet-event.com/prcomHosted over two days, ADMET 2016 aims to help attendees to:• Discover application of PBPK to drug development in rare diseases• Review the role of drug transporters in drug delivery to CNS diseases• Learn about better models for understanding, predicting and avoiding drug induced liver injury• Discuss in silico approaches to evidence-based mechanistic modelling• Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small moleculesFor those interested in attending, there is currently an early bird offer available saving £300 off of the conference price which expires on the 31st of March.ADMET 2016 is sponsored by Corning and Sekisui XenoTech.For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or amalick@smi-online.co.uk.For delegate enquiries, contact Matthew Apps on +44 (0) 207 827 6093 or mapps@smi-online.co.uk.For media enquiries, contact Zoe Gale on +44 (0) 207 827 6132 or zgale@smi-online.co.uk.11th annual ADMET conference and exhibition13-14 June 2016London, UKwww.admet-event.com/prcomContact e-mail: zgale@smi-online.co.ukContact tel: +44 (0) 207 827 6093#smiADMETAbout SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities.We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.More information can be found at http://www.smi-online.co.uk Contact Information SMi Group Zoe Gale +44 20 7827 6093 www.admet-event.com/prcom Click here to view the list of recent Press Releases from SMi Group Promote Your Business Press Release Pricing Email this page to a friend